Dupixent 300MG/2ML 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FAWBX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,890
Award facts
- Contract value 100% obligated
- $47,889.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $47,889.79 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Dupixent 300mg/2mL (dupilumab), a biologic injectable medication for atopic dermatitis and other inflammatory conditions.
The order is issued under the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent company) with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The delivery order carries a firm fixed price and an ultimate completion date of March 3, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FAWBX?
SPE2DR26FAWBX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 2, 2026.
How much is contract SPE2DR26FAWBX worth?
The government has obligated $47,890 on SPE2DR26FAWBX.
Is contract SPE2DR26FAWBX an order under another contract?
Yes. SPE2DR26FAWBX is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAWBX competed?
The extent of competition for SPE2DR26FAWBX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award